Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Buy
+5,375
New +$200K 0.1% 213
2026
Q1
Sell
-5,658
Closed -$254K 246
2025
Q4
$254K Buy
+5,658
New +$262K 0.13% 172
2025
Q3
Sell
-5,658
Closed -$272K 216
2025
Q2
$272K Hold
5,658
0.15% 154
2025
Q1
$227K Hold
5,658
0.13% 158
2024
Q4
$266K Buy
+5,658
New +$253K 0.15% 143

Other funds holding QGEN

Capital Square's QGEN Position: Q2 2026 in Review

Capital Square opened a new position in Qiagen (QGEN) in Q2 2026: 5,375 shares worth $223K. The stake represents 0.1% of the portfolio and ranks #213 among its holdings. This is a return to the name: Capital Square previously reported a position in QGEN as recently as Q4 2025.

Capital Square first reported a position in QGEN in Q4 2024 and has held it in 5 quarters since. The position peaked at $272K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Capital Square held 5,375 shares of Qiagen worth $223K as of Q2 2026.
  • Qiagen was a new Capital Square position in Q2 2026.
  • Qiagen made up 0.1% of Capital Square's portfolio in Q2 2026, its #213 holding.
  • Capital Square first reported a position in Qiagen in Q4 2024 and has held it in 5 quarters since.
  • Capital Square's Qiagen position peaked at $272K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Capital Square's 13F filing for Q2 2026, filed 13 Aug 2026.